Nucleic Acid Therapeutics
SJR Rank #1,521H-index: 85SJR: 1.950Best quartile: Q1
Publisher
Mary Ann Liebert Inc.
Country
United States
Type
journal
SJR by Edition
Subject Categories
- BiochemistryQ1
- Drug DiscoveryQ1
- GeneticsQ1
- Molecular BiologyQ1
- Molecular MedicineQ1
Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics
Most published research topics
RNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesDNA and Nucleic Acid ChemistryRNA and protein synthesis mechanismsCRISPR and Genetic EngineeringRNA Research and SplicingMicroRNA in disease regulationVirus-based gene therapy researchMuscle Physiology and DisordersRNA modifications and cancer
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
2159-3345, 2159-3337
SJR Best Quartile
Q1
Region
Northern America
Citations per Document (2 years)
5.16
References per Document
50.41
Coverage
2011-2025
Scope
Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.
Metrics from SCImago Journal Rank 2025. View on SCImago